Anti-MRC2/CD280 Antibody (Copenhagen Rigshospitalet patent anti-uPARAP)
Catalog No.
F1835
Anti-MRC2/CD280 Antibody (Copenhagen Rigshospitalet patent anti-uPARAP)
Featured Products
Copenhagen Rigshospitalet patent anti-uPARAP is a CHO-expressed humanized antibody targeting MRC2/CD280.
150 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Copenhagen Rigshospitalet patent anti-uPARAP
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9UBG0
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-MRC2/CD280 Antibody (Copenhagen Rigshospitalet patent anti-uPARAP) is more than 95%, determined by SEC-HPLC.
MRC2 / CD280
Please avoid freeze-thaw cycles.